June 2020

Caplyta From Intra-Cellular Therapies, Inc

July 06, 2020

Pharmacy Times

Caplyta is an atypical antipsychotic and is thought to exert its effect through a combination of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors.

New Regulations Aim to Reform Self-Referral Stark Law

July 02, 2020

Pharmacy Times

When the Stark Law, or ethics in patient referrals act, was passed in 1989, its purpose was to prevent physicians from referring patients to designated health service entities in which they had financial interest.

Stay Up to Date on New COVID-19 Data in Specific Populations

June 15, 2020

Pharmacy Times

As the overall data on this illness continue to emerge, it will be important for health care providers to watch its impact on different populations and to serve as a source of reliable information for them.